Dr. Sepehr Keyhani, MD

Dr. Keyhani practices at Mission District Dialysis in San Francisco, California.

Dr. Keyhani's NPI, 1952713570, was assigned on June 2, 2014. Dr. Keyhani graduated from UC San Diego School of Medicine in 2014. Dr. Keyhani holds California license A141031.

Dr. Keyhani's primary practice is Mission District Dialysis, at 2100 Webster St, San Francisco, CA 94115 in San Francisco County. The practice phone is (628) 600-8705.

Dr. Keyhani's primary practice is Mission District Dialysis in San Francisco, California. Dr. Keyhani is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is Renal Medical Associates. Dmand AI also links Dr. Keyhani to 3 more hospitals, 4 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Keyhani practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Keyhani's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Keyhani is board certified in internal medicine by the American Board of Internal Medicine. Dr. Keyhani is licensed in California.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances, gout, hypercalcemia and kidney disease among the conditions Dr. Keyhani treats.

CMS data shows 1,620 Medicare services from Dr. Keyhani across 8 procedure codes in 2024, for 468 Medicare patients. Medicare paid $242,016 for them.

CMS counts 468 Medicare patients who saw Dr. Keyhani in 2024. The largest group is 75 to 84, with 165 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 55% are also on Medicaid. Their average risk score is 4.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Keyhani's median patient age at 76, with 36% women.

In 2024, Dr. Keyhani wrote 2,588 Medicare Part D claims for 303 patients. 83% of them were for generic drugs. CMS names the drug for 2,373 of them, across 45 drugs with 11 or more claims each, at $423,021 in total drug cost. In 2023, CMS named 1,666 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Keyhani for performance year 2024, reported as part of a group. Dr. Keyhani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Keyhani as offering telehealth.

Dmand AI links 2 papers to Dr. Keyhani, published from 2011 to 2016. The most frequent topics are Bacterial Proteins, Magnetosomes and Magnetospirillum.

CMS Open Payments shows 4 general payments to Dr. Keyhani from 4 drug and device companies from 2016 to 2017. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $45.

Dr. Keyhani graduated from UC San Diego School of Medicine in 2014.

Dr. Keyhani is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.